The pharmaceutical company Reig Jofre, a member of CATALONIA.HEALTH, has signed a commercial agreement with LEO Pharma, with the aim to strengthen the promotion of LEO Pharma’s innovative treatment for mild to moderate psoriasis within the scope of Primary Care in Spain.
This agreement marks a significant milestone in positioning Reig Jofre and LEO Pharma as key players in medical dermatology in Spain. LEO Pharma demonstrates its trust in Reig Jofre as a strategic partner. This collaboration ensures that healthcare professionals receive the support, proximity, and information needed to provide the best possible care to their patients.
Through this alliance, both companies strengthen their shared commitment to universalize the science that matters, making scientifically validated and effective therapeutic solutions accessible to as many patients as possible. Through innovation, excellence and ongoing support for healthcare professionals, both companies move forward with their shared purpose of improving people’s quality of life and ensuring equitable access to essential health treatments.
Comments